Delivery Order SPE2DB20D1100-SPE2DB25FD9T9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,358.37 to AmerisourceBergen Drug Corp for 100 units of Depakote DR 125 mg Sprinkle capsules, with a completion deadline of July 21, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a direct procurement of pharmaceutical inventory to support federal healthcare operations. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Depakote DR 125 mg Sprinkle capsules (100-count packaging) with a ceiling value of $5,463.37. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 19, 2025, and performance to occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Depakote DR 125 mg sprinkle capsules (100-count unit) valued at $1,458.55. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award utilized firm fixed pricing with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $3,014.25 to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single shipment of this anticonvulsant and mood-stabilizing medication,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,003.25 to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100-count units). This firm fixed-price delivery order, issued on August 15, 2025, with a completion date of August 18, 2025, represents a non-set-aside award. The product will be performed at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,506.66 to AmerisourceBergen Drug Corp for 100 tablets of Depakote DR 250 mg on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order valued at $1,605.84 to AmerisourceBergen Drug Corp for 100 sprinkle capsules of Depakote DR 125 mg, an anticonvulsant and mood-stabilizing medication commonly used in military and veteran healthcare systems. This non-set-aside contract reflects a firm fixed price arrangement with a place of performance in Conshohocken, Pennsylvania, and was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.44 to AmerisourceBergen Drug Corp for DEPAKOTE ER 500 mg tablets (100-count) on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract utilizes firm fixed pricing and represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.29 firm fixed-price contract is for the delivery of Depakote DR 125 mg medication sprinkle capsules. It is an open competition contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Depakote ER 500 mg tablets (100-count units) with a ceiling value of $1,357.91. This is a firm fixed-price, non-set-aside delivery order contract with an ultimate completion date of September 8, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9T9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,092.44 to AmerisourceBergen Drug Corp for 100 units of Depakote DR 125 mg Sprinkle capsules, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, including neurological treatments such as Depakote, to support military and defense healthcare systems. The company's federal contract awards demonstrate consistent capability in meeting competitive procurement requirements across multiple therapeutic domains and delivery scales, ranging from small-value transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/11/25 |